“Let’s start with something simple. I cannot recall a time this year when it feels this good to be diversified among a whole host of terrific...
My top 10 things to watch Monday, Nov. 10 1. The S & P 500 was tracking for a higher open this morning after Senate lawmakers...
Third-quarter earnings reports, the Federal Reserve’s latest rate decision, and developments in the China-U.S. trade war led to some wild swings in the stock market. However,...
Bristol Myers Squibb ‘s beat-and-raise quarter wasn’t enough to change our cautious view on the stock as we await updates on one of its promising drugs....
These are the stocks posting the largest moves midday. Source link
We are selling 300 shares of Bristol Myers Squibb at roughly $44.35. Following the trade, Jim Cramer’s Charitable Trust will own 1,100 shares of Bristol Myers,...
My top 10 things to watch Thursday, Oct. 30 1. Stocks were headed for a modestly lower open this morning following the Fed’s second interest rate...
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading...
Investors are noticing ripe opportunity in Cytokinetics, a late-stage biopharma company targeting medicines for specialty heart diseases, that has seen shares skyrocket in recent months. Shares...
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg |...
